Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil in Stable Angina (SIGMART)
NCT01396395Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Sep 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicorandil in stable angina, sponsored by Merck KGaA. Started Sep 2011; status: completed.
02
Drugs
nicorandil
03
Conditions
stable angina
Beyond the preview
Go deeper on NCT01396395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01396395.